Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases.


Journal

Clinical microbiology reviews
ISSN: 1098-6618
Titre abrégé: Clin Microbiol Rev
Pays: United States
ID NLM: 8807282

Informations de publication

Date de publication:
15 12 2021
Historique:
pubmed: 12 8 2021
medline: 3 2 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

Parasitic neglected tropical diseases (NTDs) affect over one billion people worldwide, with individuals from communities in low-socioeconomic areas being most at risk and suffering the most. Disease management programs are hindered by the lack of infrastructure and resources for clinical sample collection, storage, and transport and a dearth of sensitive diagnostic methods that are inexpensive as well as accurate. Many diagnostic tests and tools have been developed for the parasitic NTDs, but the collection and storage of clinical samples for molecular and immunological diagnosis can be expensive due to storage, transport, and reagent costs, making these procedures untenable in most areas of endemicity. The application of membrane technology, which involves the use of specific membranes for either sample collection and storage or diagnostic procedures, can streamline this process, allowing for long-term sample storage at room temperature. Membrane technology can be used in serology-based diagnostic assays and for nucleic acid purification prior to molecular analysis. This facilitates the development of relatively simple and rapid procedures, although some of these methods, mainly due to costs, lack accessibility in low-socioeconomic regions of endemicity. New immunological procedures and nucleic acid storage, purification, and diagnostics protocols that are simple, rapid, accurate, and cost-effective must be developed as countries progress control efforts toward the elimination of the parasitic NTDs.

Identifiants

pubmed: 34378956
doi: 10.1128/CMR.00329-20
pmc: PMC8404699
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0032920

Subventions

Organisme : Department of Health, Australian Government | National Health and Medical Research Council (NHMRC)
ID : APP1160046

Auteurs

Madeleine J Rogers (MJ)

School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Queensland, Australia.

Donald P McManus (DP)

Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Queensland, Australia.

Stephen Muhi (S)

Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Catherine A Gordon (CA)

Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH